Sin conexión a internet: se muestra la versión guardada de la página.

Orion Oyj B

FIEUR
← Al Screener

Orion Oyj B (LSE:0M2O) — Drug Manufacturers - General. Número de bolsas en las que cotizan las acciones de la empresa: 3. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la Empresa

Sitio Web
orionpharma.com
Sector
Healthcare · Drug Manufacturers - General
Sede Central
Espo, Finland
Consejero Delegado
Liisa Hurme
Empleados
4 000
Cotiza Desde
07.11.2007 (LSE:0M2O)
Acciones en Circulación
108.99 M
Capital Flotante
123.49 M
Capitalización Bursátil
11.42 mil M EUR
Insiders
2.63%
Inversores Institucionales
45.48%
Ratio de Reparto
41.3%
FCF
380 M EUR
Pagos / FCF
64%
Deuda
133 M EUR
0.3 a. de FCF
Racha de Dividendos
21 a.
Beneficios, FCF y dividendos pagados — para los 12 meses hasta 30.06.2026 (el último informe de la compañía).
Descripción

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflammatory pain; Divina series for menopausal symptoms; Simdax for acute decompensated heart failure; Fareston for breast cancer; Quetiapine products for antipsychotic; Trexan for rheumatoid arthritis and cancer; Easyhaler product portfolio for asthma and COPD; and Dexdor, Precedex, and Dexmedetomidine products for human use. The company also provides Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, it offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells drugs and products manufactured by other companies. Additionally, the company provides self-care products, including non-prescription medicines, cosmetics, dietary supplements, vitamins, and skincare products. It also offers its products online. The company has a licensing agreement with Tenax Therapeutics, Inc. to develop oral levosimendan (TNX-103) for pulmonary hypertension in heart failure with preserved ejection fraction (PH-HFpEF); and Bayer for the development and commercialisation of darolutamide Nubeqa. Orion Oyj was founded in 1917 and is headquartered in Espo, Finland.

anuncio

Bolsas y Tickers

BolsaTickerMonedaPrecioTipo
HE Nasdaq HelsinkiORNBV principalEUR80.8 -0.12%acciones ordinarias
LSE London Stock Exchange0M2O IOBEUR45.86 +0.00%acciones ordinarias
US USA StocksORINF OTCUSD92.05 +0.00%acciones ordinarias

Precio en 3 Meses

día alcista día bajista fecha ex-dividendo fecha de pagoPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Dividendos

Próxima fecha ex: 2026-10-20 · 0.9 EUR (US:ORINF)
Por año, US:ORINF: ≈1.8 EUR (1 pagos)
Por año, HE:ORNBV: 0.9 EUR (1 pagos)

Orion Oyj B (ORINF) paga dividendos dos veces al año. Por año (12 meses hasta e incluyendo el último pago anunciado): 1.8 EUR por acción (pagos: 1). La próxima fecha ex-dividendo es el 20.10.2026: 0.9 EUR por acción, con pago el 27.10.2026. Historial de dividendos ininterrumpido: 21 años.

Fecha ExPagoImporte%TipoTicker
2026-10-20 anunciado2026-10-270.9000 EUR1.1/2.2 %semestralUS:ORINF
2026-03-252026-04-020.9000 EUR1.3/2.6 %semestralHE:ORNBV
2025-10-152025-10-230.8200 EUR1.2/2.4 %semestralHE:ORNBV
2025-04-042025-04-140.8200 EUR1.5/2.9 %semestralHE:ORNBV
2024-10-152024-10-230.8100 EUR1.7/3.4 %semestralHE:ORNBV
2024-03-212024-04-030.8100 EUR2.3/2.3 %anualHE:ORNBV
2023-03-23—1.6000 EUR3.7/3.7 %anualHE:ORNBV
2022-03-24—1.5000 EUR3.5/3.5 %anualHE:ORNBV

Principales Accionistas

TitularParticipaciónAccionesFecha del Informe
BlackRock, Inc.≈6.43%7.07 M2025-04-24
VANGUARD STAR FUNDS-Vang…1.42%1.56 M2026-07-31
VANGUARD TAX-MANAGED FUN…0.95%1.04 M2026-06-30
iShares Trust-iShares Co…0.75%825 3442026-08-31
DFA INVESTMENT TRUST CO-…0.55%600 7792026-07-31
DFA INVESTMENT DIMENSION…0.45%497 9172026-07-31
Fidelity Concord Street…0.39%426 2452026-07-31
iShares Trust-iShares MS…0.35%379 6642026-08-31
SPDR-EUROPE-SSgA SPDR ET…0.34%374 2452026-07-31
VANGUARD Intl Eqy. INDEX…0.23%254 0972026-07-31
VANGUARD Intl Eqy. INDEX…0.23%253 8582026-07-31
Pacer Advisors, Inc.0%4852026-06-30